IDEXX LABORATORIES INC /DE Amortization of Debt Discount (Premium)
IDEXX LABORATORIES INC /DE (IDXX) reported Amortization of Debt Discount (Premium) of -$5.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2019-02-15
- IDEXX LABORATORIES INC /DE amortization of debt discount (premium) for the quarter ending 2016-12-31 was $116.00K, a 75.05% decline year-over-year.
- IDEXX LABORATORIES INC /DE amortization of debt discount (premium) for the quarter ending 2015-12-31 was $465.00K.
- IDEXX LABORATORIES INC /DE amortization of debt discount (premium) for the quarter ending 2015-03-31 was $91.00K.
- IDEXX LABORATORIES INC /DE amortization of debt discount (premium) for fiscal 2018 was -$5.00K, a 113.16% decline from fiscal 2017.
- IDEXX LABORATORIES INC /DE amortization of debt discount (premium) for fiscal 2017 was $38.00K, a 95.49% decline from fiscal 2016.
- IDEXX LABORATORIES INC /DE amortization of debt discount (premium) for fiscal 2016 was $843.00K, a 41.13% decline from fiscal 2015.
- IDEXX LABORATORIES INC /DE amortization of debt discount (premium) for fiscal 2015 was $1.43M.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|
| 2018-12-31 | -$5.00K 10-K · filed 2019-02-15 | ||
| 2017-12-31 | $38.00K 10-K · filed 2019-02-15 | ||
| 2016-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $843.00K 10-K · filed 2019-02-15 | |
| 2016-09-30 | $727.00K 10-Q · filed 2016-11-01 | ||
| 2015-12-31 | $465.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.43M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $967.00K 10-Q · filed 2016-11-01 | ||
| 2015-03-31 | $91.00K 10-Q · filed 2015-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |